Published in Vaccine on March 15, 2002
Identification of a Moraxella catarrhalis outer membrane protein exhibiting both adhesin and lipolytic activities. Infect Immun (2003) 1.36
The Moraxella catarrhalis porin-like outer membrane protein CD is an adhesin for human lung cells. Infect Immun (2004) 1.30
The Hag protein of Moraxella catarrhalis strain O35E is associated with adherence to human lung and middle ear cells. Infect Immun (2003) 1.26
The immunoglobulin D-binding protein MID from Moraxella catarrhalis is also an adhesin. Infect Immun (2003) 1.21
Molecular aspects of Moraxella catarrhalis pathogenesis. Microbiol Mol Biol Rev (2009) 1.19
The UspA2 protein of Moraxella catarrhalis is directly involved in the expression of serum resistance. Infect Immun (2005) 1.16
Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade. Infect Immun (2006) 1.10
Moraxella catarrhalis strain O35E expresses two filamentous hemagglutinin-like proteins that mediate adherence to human epithelial cells. Infect Immun (2007) 1.07
Salivary antibodies directed against outer membrane proteins of Moraxella catarrhalis in healthy adults. Infect Immun (2003) 1.01
The Moraxella catarrhalis autotransporter McaP is a conserved surface protein that mediates adherence to human epithelial cells through its N-terminal passenger domain. Infect Immun (2006) 0.97
Cold shock response of the UspA1 outer membrane adhesin of Moraxella catarrhalis. Infect Immun (2005) 0.95
Identification of gene products involved in biofilm production by Moraxella catarrhalis ETSU-9 in vitro. Infect Immun (2007) 0.88
Characterization of the molecular interplay between Moraxella catarrhalis and human respiratory tract epithelial cells. PLoS One (2013) 0.87
Characterization of a novel porin protein from Moraxella catarrhalis and identification of an immunodominant surface loop. J Bacteriol (2005) 0.86
Identification of a bacteriocin and its cognate immunity factor expressed by Moraxella catarrhalis. BMC Microbiol (2009) 0.85
A conserved tetranucleotide repeat is necessary for wild-type expression of the Moraxella catarrhalis UspA2 protein. J Bacteriol (2006) 0.85
Vaccine targets against Moraxella catarrhalis. Expert Opin Ther Targets (2015) 0.84
Antibodies specific for the Hia adhesion proteins of nontypeable Haemophilus influenzae mediate opsonophagocytic activity. Clin Vaccine Immunol (2009) 0.84
Moraxella catarrhalis coaggregates with Streptococcus pyogenes and modulates interactions of S. pyogenes with human epithelial cells. Infect Immun (2004) 0.83
Selection and Counterselection of Hia Expression Reveals a Key Role for Phase-Variable Expression of Hia in Infection Caused by Nontypeable Haemophilus influenzae. J Infect Dis (2015) 0.80
A UspA2H-negative variant of Moraxella catarrhalis strain O46E has a deletion in a homopolymeric nucleotide repeat common to uspA2H genes. Infect Immun (2007) 0.79
Moraxella catarrhalis adhesin UspA1-derived recombinant fragment rD-7 induces monocyte differentiation to CD14+CD206+ phenotype. PLoS One (2014) 0.75
Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study. J Clin Oncol (2010) 1.81
Obstructive sleep-disordered breathing and fasting insulin levels in nonobese children. Pediatr Pulmonol (2005) 1.70
Black hairy tongue in a 2-month-old infant. J Paediatr Child Health (2008) 1.69
Mycoplasma pneumoniae associated opsoclonus-myoclonus syndrome in three cases. Eur J Pediatr (2009) 1.59
Viral etiology of acute respiratory infections with cough in infancy: a community-based birth cohort study. Pediatr Infect Dis J (2008) 1.57
Real-time quantitative broad-range PCR assay for detection of the 16S rRNA gene followed by sequencing for species identification. J Clin Microbiol (2006) 1.49
Antibiotic use for upper respiratory tract infections in children: a cross-sectional survey of knowledge, attitudes, and practices (KAP) of parents in Greece. BMC Pediatr (2011) 1.38
Serum concentrations of lectin-pathway components in healthy neonates, children and adults: mannan-binding lectin (MBL), M-, L-, and H-ficolin, and MBL-associated serine protease-2 (MASP-2). Pediatr Allergy Immunol (2011) 1.25
Antibiotic therapy for pediatric community-acquired pneumonia: do we know when, what and for how long to treat? Pediatr Infect Dis J (2012) 1.19
The UspA2 protein of Moraxella catarrhalis is directly involved in the expression of serum resistance. Infect Immun (2005) 1.16
Mycobacterium bohemicum cervical lymphadenitis. Pediatr Infect Dis J (2002) 1.15
Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents. Eur J Pediatr (2005) 1.14
How do physicians immunize their own children? Differences among pediatricians and nonpediatricians. Pediatrics (2005) 1.13
Identification of surface antigens of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease. Infect Immun (2005) 1.10
Mucosal immune response to specific outer membrane proteins of Moraxella catarrhalis in young children. Pediatr Infect Dis J (2003) 1.08
Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection. Med Pediatr Oncol (2003) 1.07
Development and assessment of a questionnaire for a descriptive cross-sectional study concerning parents' knowledge, attitudes and practises in antibiotic use in Greece. BMC Infect Dis (2009) 1.06
Resistance to erythromycin and telithromycin in Streptococcus pyogenes isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: phenotypic and genotypic analysis. Antimicrob Agents Chemother (2006) 1.05
Physiologic cold shock increases adherence of Moraxella catarrhalis to and secretion of interleukin 8 in human upper respiratory tract epithelial cells. J Infect Dis (2009) 1.01
Salivary antibodies directed against outer membrane proteins of Moraxella catarrhalis in healthy adults. Infect Immun (2003) 1.01
Impact of heptavalent pneumococcal conjugate vaccine on nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among day-care center attendees in central Greece. Pediatr Infect Dis J (2008) 1.00
Adiposity in relation to age as predictor of severity of sleep apnea in children with snoring. Sleep Breath (2008) 0.99
A reservoir of Moraxella catarrhalis in human pharyngeal lymphoid tissue. J Infect Dis (2007) 0.99
Differential role of the lectin pathway of complement activation in susceptibility to neonatal sepsis. Clin Infect Dis (2010) 0.98
Antigenic specificity of the mucosal antibody response to Moraxella catarrhalis in chronic obstructive pulmonary disease. Infect Immun (2005) 0.98
Deficiency of mannose-binding lectin-associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients. Pediatr Infect Dis J (2007) 0.97
Outer membrane protein UspA1 and lipooligosaccharide are involved in invasion of human epithelial cells by Moraxella catarrhalis. Microbes Infect (2007) 0.95
Predicting bacteremia in children with fever and chemotherapy-induced neutropenia. Pediatr Infect Dis J (2004) 0.95
Cold shock response of the UspA1 outer membrane adhesin of Moraxella catarrhalis. Infect Immun (2005) 0.95
Voriconazole-induced phototoxicity in children. Pediatr Infect Dis J (2012) 0.94
Dynamics of Streptococcus pneumoniae nasopharyngeal carriage with high heptavalent pneumococcal conjugate vaccine coverage in Central Greece. Vaccine (2011) 0.94
Fusidic acid and clindamycin resistance in community-associated, methicillin-resistant Staphylococcus aureus infections in children of Central Greece. BMC Infect Dis (2010) 0.94
Anti-inflammatory pharmacotherapy for wheezing in preschool children. Pediatr Pulmonol (2007) 0.93
Congenital H-ficolin deficiency in premature infants with severe necrotising enterocolitis. Gut (2010) 0.90
Twelve years' detection of respiratory viruses by immunofluorescence in hospitalised children: impact of the introduction of a new respiratory picornavirus assay. BMC Infect Dis (2011) 0.90
Fatal adenovirus hepatitis during maintenance therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer (2008) 0.89
Mansonella perstans causing symptomatic hypereosinophilia in a missionary family. Travel Med Infect Dis (2005) 0.89
Hyperlipidemia in HIV-infected children treated with protease inhibitors: relevance for cardiovascular diseases. J Acquir Immune Defic Syndr (2002) 0.89
Unveiling electrotransformation of Moraxella catarrhalis as a process of natural transformation. FEMS Microbiol Lett (2006) 0.87
Predicting bacteremia in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study. Pediatr Infect Dis J (2011) 0.87
Moraxella catarrhalis strains with reduced expression of the UspA outer membrane proteins belong to a distinct subpopulation. Vaccine (2005) 0.87
Topical curcumin can inhibit deleterious effects of upper respiratory tract bacteria on human oropharyngeal cells in vitro: potential role for patients with cancer therapy induced mucositis? Support Care Cancer (2010) 0.86
Real-time broad-range PCR versus blood culture. A prospective pilot study in pediatric cancer patients with fever and neutropenia. Support Care Cancer (2007) 0.86
Antimicrobial susceptibility and macrolide resistance inducibility of Streptococcus pneumoniae carrying erm(A), erm(B), or mef(A). Antimicrob Agents Chemother (2003) 0.86
Prevalence of nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) in children a multicenter cross-sectional study. Pediatr Infect Dis J (2007) 0.86
Physiologic cold shock of Moraxella catarrhalis affects the expression of genes involved in the iron acquisition, serum resistance and immune evasion. BMC Microbiol (2011) 0.85
Down-regulation of porin M35 in Moraxella catarrhalis by aminopenicillins and environmental factors and its potential contribution to the mechanism of resistance to aminopenicillins. J Antimicrob Chemother (2010) 0.85
Economic evaluation of varicella vaccination in Swiss children and adolescents. Hum Vaccin (2009) 0.85
Immunofluorescence versus xTAG multiplex PCR for the detection of respiratory picornavirus infections in children. J Clin Virol (2010) 0.85
Serious medical complications in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study. Pediatr Blood Cancer (2011) 0.85
A multicenter, cross-sectional study on the prevalence and risk factors for nasal colonization with Staphylococcus aureus in patients admitted to children's hospitals in Switzerland. Clin Infect Dis (2008) 0.85
Antimicrobial use and serotype distribution of nasopharyngeal Streptococcus pneumoniae isolates recovered from Greek children younger than 2 years old. Clin Infect Dis (2002) 0.84
Antibacterial and antiinflammatory kinetics of curcumin as a potential antimucositis agent in cancer patients. Nutr Cancer (2012) 0.84
Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection? Clin Vaccine Immunol (2006) 0.84
M-ficolin in the neonatal period: Associations with need for mechanical ventilation and mortality in premature infants with necrotising enterocolitis. Mol Immunol (2009) 0.83
Frequency, clinical characteristics, and genotype distribution of rotavirus gastroenteritis in Greece (2007-2008). J Med Virol (2011) 0.83
Failure of voriconazole to cure disseminated zygomycosis in an immunocompromised child. Eur J Pediatr (2005) 0.83
Determinants of vaccine immunity in the cohort of human immunodeficiency virus-infected children living in Switzerland. Pediatr Infect Dis J (2009) 0.83
Copeptin concentration in cord blood in infants with early-onset sepsis, chorioamnionitis and perinatal asphyxia. BMC Pediatr (2011) 0.82
M-ficolin concentrations in cord blood are related to circulating phagocytes and to early-onset sepsis. Pediatr Res (2012) 0.82
Incidence and Outcome of Group B Streptococcal Sepsis in Infants in Switzerland. Pediatr Infect Dis J (2016) 0.81
Two dosages of clarithromycin for five days, amoxicillin/clavulanate for five days or penicillin V for ten days in acute group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J (2004) 0.81
Seven-year surveillance of emm types of pediatric Group A streptococcal pharyngitis isolates in Western Greece. PLoS One (2013) 0.81
Serum C-reactive protein in children with adenovirus infection. Swiss Med Wkly (2002) 0.81
Evaluation of potential medical and economic benefits of universal rotavirus vaccination in Greece. Acta Paediatr (2011) 0.81
Rapid typing of Moraxella catarrhalis subpopulations based on outer membrane proteins using mass spectrometry. Proteomics (2006) 0.81
Prevalence of nosocomial infections in Swiss children's hospitals. Infect Control Hosp Epidemiol (2004) 0.81
RNA-Seq-based analysis of the physiologic cold shock-induced changes in Moraxella catarrhalis gene expression. PLoS One (2013) 0.81
Macrolide resistance determinants among Streptococcus pneumoniae isolates from carriers in Central Greece. BMC Infect Dis (2012) 0.81
Good agreement between capillary and venous sampling for lectin pathway proteins. Immunobiology (2012) 0.81
Granulocyte colony-stimulating factor-responsive chronic neutropenia in cartilage-hair hypoplasia. J Pediatr Hematol Oncol (2004) 0.80
Mannose-binding lectin cord blood levels and respiratory symptoms during infancy: a prospective birth cohort study. Pediatr Allergy Immunol (2008) 0.80
European ST80 community-associated methicillin-resistant Staphylococcus aureus orbital cellulitis in a neonate. BMC Ophthalmol (2012) 0.80
Risk prediction of fever in neutropenia in children with cancer: a step towards individually tailored supportive therapy? Pediatr Blood Cancer (2008) 0.80
Molecular pathogenesis of infections caused by Moraxella catarrhalis in children. Swiss Med Wkly (2012) 0.80
Prospective surveillance of varicella-zoster virus infections in an out-patient setting in Switzerland. Hum Vaccin (2009) 0.80
Attitudes regarding occupational vaccines and vaccination coverage against vaccine-preventable diseases among healthcare workers working in pediatric departments in Greece. Pediatr Infect Dis J (2012) 0.79
Immune response to influenza vaccination in children treated with methotrexate or/and tumor necrosis factor-alpha inhibitors. Hum Vaccin (2011) 0.78
Outer membrane porin M35 of Moraxella catarrhalis mediates susceptibility to aminopenicillins. BMC Microbiol (2009) 0.78
Impact of the availability of an influenza virus rapid antigen test on diagnostic decision making in a pediatric emergency department. Pediatr Emerg Care (2013) 0.78